James Love on Mon, 29 Mar 1999 23:02:11 +0200 (CEST) |
[Date Prev] [Date Next] [Thread Prev] [Thread Next] [Date Index] [Thread Index]
<nettime> FT: Campaign over drug licensing to grow |
[orig to RANDOM-BITS <random-bits@essential.org>] Financial Times Monday, March 29, 1999 Lead paragraph on page one, full story on page 3 Campaign over drug licensing to grow by Francis Williams in Geneva Aids activists and other health and consumer groups plan to step up their campaign against US government policy on compulsory licensing of pharmaceuticals patents, which they claim is depriving people in poor countries of life-saving drugs. Washington has threatened sanctions against countries such as Thailand and South Africa for exercising what groups claim are their legal rights to insist on compulsory licenses for certain drugs which are not available or affordable locally. International patent law and world trade rules allow governments to issue a compulsory license, enabling a local company to produce a patented drug, if this is judged to be in the public interest and reasonable terms cannot be negotiated with the patent owner. US policy came under a strong attack at a meeting on Friday of some 60 non-governmental organizations from around the world with representatives of the pharmaceutical industry, governments and international bodies including the World Health Organization (WHO) and the World Trade Organization (WTO). Bernard Pecoul of Medecins Sans Frontieres (MSF), which is trying to improve access to essential drugs, said access had worsened in recent years. The emergence of new diseases such as HIV/Aids and drug resistant strains of old ones such as tuberculosis or malaria meant that, increasingly, effective drugs tended to be protected by patents. Health groups say the drugs are too expensive or are not sold in developing countries to avoid undercutting lucrative markets in the US and Europe. The big US and European pharmaceutical companies argue that compulsory licensing acts as a disincentive to research and development. --- # distributed via nettime-l : no commercial use without permission # <nettime> is a closed moderated mailinglist for net criticism, # collaborative text filtering and cultural politics of the nets # more info: majordomo@desk.nl and "info nettime-l" in the msg body # URL: http://www.desk.nl/~nettime/ contact: nettime-owner@desk.nl